Sanofi (BKK:SANOFI80)

Market Cap	3.68T
Revenue (ttm)	1.74T
Net Income (ttm)	348.08B
Shares Out	n/a
EPS (ttm)	280.83
PE Ratio	10.57
Forward PE	9.84
Dividend	0.10 (3.48%)
Ex-Dividend Date	May 13, 2025

Volume	598,119
Average Volume	138,471
Open	3.080
Previous Close	3.100
Day's Range	2.900 - 3.100
52-Week Range	2.900 - 4.800
Beta	n/a
RSI	29.27
Earnings Date	Oct 24, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: SANOFI80

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial numbers in EUR